AstraZeneca
The Executive Director, Biometrics – CVRM leads the biometrics strategy for AstraZeneca's cardiovascular, renal, and metabolic therapy area, overseeing statistical design, analysis, and regulatory contributions across global clinical development programs. This senior leader drives organizational change, productivity improvements, and the adoption of AI-enabled tools to ensure robust, decision‑relevant evidence throughout the drug development lifecycle.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.